Górecka D, Gawinkowska A, Szwoch-Bukowska A, Jedrzejczak M, Remiszewski W, Papuziński K, Bień M, Szafrański W, Nykiel E, Kisło A
Kliniki Chorób Płuc Instytutu Gruźlicy i Chorób Płuc, Warszawie.
Pneumonol Alergol Pol. 1992;60(9-10):28-35.
Accuracy of qualification to LTOT and the results of one year of treatment were assessed in 12 regional centres in Poland. 390 patients with advances respiratory failure entered the study. There were 305 patients with COPD and 85 patients with other chronic lung diseases. The accuracy of qualification to LTOT in Poland is satisfactory--2/3 of patients were accepted to treatment with severe hypoxaemia (PaO2 55 mm Hg), the remainder with moderate hypoxaemia (PaO2 = 56-65 mm Hg) and signs of tissue hypoxia. After one year of treatment 6.5% of patients did not need LTOT and 13% stopped to fulfill the single entry criterion still needing treatment.
波兰12个地区中心评估了长期氧疗（LTOT）的资格认定准确性以及一年的治疗结果。390例晚期呼吸衰竭患者进入研究。其中慢性阻塞性肺疾病（COPD）患者305例，其他慢性肺部疾病患者85例。波兰LTOT资格认定的准确性令人满意——三分之二的严重低氧血症（动脉血氧分压[PaO2] 55 mmHg）患者被接受治疗，其余中度低氧血症（PaO2 = 56 - 65 mmHg）且有组织缺氧体征的患者也接受治疗。经过一年的治疗，6.5%的患者不再需要LTOT，13%的患者不再满足单一入组标准但仍需治疗。
